Abstract
Circulating Tumor DNA Integrated with Interim [18F]FDG PET Is Highly Effective in Predicting Outcome of Relapsed/Refractory Classical Hodgkin Lymphoma Treated with the Begev Regimen
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have